

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * complement activation, alternative pathway (GO:0006957) | 9.12111455 |
| 2 | exogenous drug catabolic process (GO:0042738) | 8.88506633 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 8.76050090 |
| 4 | omega-hydroxylase P450 pathway (GO:0097267) | 8.72421281 |
| 5 | regulation of protein activation cascade (GO:2000257) | 8.71492570 |
| 6 | drug catabolic process (GO:0042737) | 8.70978699 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 8.30130650 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 8.30130650 |
| 9 | regulation of complement activation (GO:0030449) | 8.18535756 |
| 10 | glyoxylate metabolic process (GO:0046487) | 8.03512514 |
| 11 | regulation of fibrinolysis (GO:0051917) | 7.92932485 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.60699780 |
| 13 | L-phenylalanine metabolic process (GO:0006558) | 7.60699780 |
| 14 | negative regulation of fibrinolysis (GO:0051918) | 7.47739976 |
| 15 | urea metabolic process (GO:0019627) | 6.99432217 |
| 16 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.44948196 |
| 17 | protein carboxylation (GO:0018214) | 6.44948196 |
| 18 | nitrogen cycle metabolic process (GO:0071941) | 6.36102671 |
| 19 | ethanol oxidation (GO:0006069) | 6.31347351 |
| 20 | cellular glucuronidation (GO:0052695) | 6.29075781 |
| 21 | drug metabolic process (GO:0017144) | 6.19280734 |
| 22 | fibrinolysis (GO:0042730) | 6.06821806 |
| 23 | urea cycle (GO:0000050) | 6.01937296 |
| 24 | oxidative demethylation (GO:0070989) | 6.01141784 |
| 25 | glucuronate metabolic process (GO:0019585) | 5.96789033 |
| 26 | uronic acid metabolic process (GO:0006063) | 5.96789033 |
| 27 | blood coagulation, intrinsic pathway (GO:0007597) | 5.96639832 |
| 28 | bile acid biosynthetic process (GO:0006699) | 5.95214018 |
| 29 | aromatic amino acid family catabolic process (GO:0009074) | 5.92984978 |
| 30 | regulation of triglyceride catabolic process (GO:0010896) | 5.91717722 |
| 31 | serine family amino acid catabolic process (GO:0009071) | 5.89808636 |
| 32 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.69577236 |
| 33 | * protein activation cascade (GO:0072376) | 5.54396731 |
| 34 | complement activation, classical pathway (GO:0006958) | 5.38192287 |
| 35 | * complement activation (GO:0006956) | 5.34569545 |
| 36 | negative regulation of cholesterol transport (GO:0032375) | 5.30672862 |
| 37 | negative regulation of sterol transport (GO:0032372) | 5.30672862 |
| 38 | negative regulation of protein activation cascade (GO:2000258) | 5.30282135 |
| 39 | bile acid metabolic process (GO:0008206) | 5.30030254 |
| 40 | opsonization (GO:0008228) | 5.28589563 |
| 41 | imidazole-containing compound metabolic process (GO:0052803) | 5.23855068 |
| 42 | regulation of humoral immune response (GO:0002920) | 5.17942197 |
| 43 | ethanol metabolic process (GO:0006067) | 5.06162856 |
| 44 | acute-phase response (GO:0006953) | 5.05857740 |
| 45 | regulation of plasminogen activation (GO:0010755) | 5.05526092 |
| 46 | phenylpropanoid metabolic process (GO:0009698) | 5.01559339 |
| 47 | glycine metabolic process (GO:0006544) | 4.95857514 |
| 48 | bile acid and bile salt transport (GO:0015721) | 4.93314625 |
| 49 | tyrosine metabolic process (GO:0006570) | 4.89160380 |
| 50 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.86280191 |
| 51 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.85110197 |
| 52 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.85110197 |
| 53 | cytolysis (GO:0019835) | 4.70797547 |
| 54 | S-adenosylmethionine metabolic process (GO:0046500) | 4.69424726 |
| 55 | negative regulation of blood coagulation (GO:0030195) | 4.63748308 |
| 56 | negative regulation of hemostasis (GO:1900047) | 4.63748308 |
| 57 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.62529128 |
| 58 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.62529128 |
| 59 | triglyceride homeostasis (GO:0070328) | 4.48539457 |
| 60 | acylglycerol homeostasis (GO:0055090) | 4.48539457 |
| 61 | hormone catabolic process (GO:0042447) | 4.43690059 |
| 62 | protein-lipid complex remodeling (GO:0034368) | 4.33148352 |
| 63 | macromolecular complex remodeling (GO:0034367) | 4.33148352 |
| 64 | plasma lipoprotein particle remodeling (GO:0034369) | 4.33148352 |
| 65 | negative regulation of wound healing (GO:0061045) | 4.26735379 |
| 66 | alkaloid metabolic process (GO:0009820) | 4.25844696 |
| 67 | negative regulation of complement activation (GO:0045916) | 4.23210807 |
| 68 | glutamate metabolic process (GO:0006536) | 4.21727655 |
| 69 | phospholipid efflux (GO:0033700) | 4.21212091 |
| 70 | negative regulation of coagulation (GO:0050819) | 4.20132369 |
| 71 | flavonoid metabolic process (GO:0009812) | 4.05973926 |
| 72 | serine family amino acid metabolic process (GO:0009069) | 4.05950090 |
| 73 | alpha-amino acid catabolic process (GO:1901606) | 4.01854641 |
| 74 | positive regulation of blood coagulation (GO:0030194) | 3.99479886 |
| 75 | positive regulation of hemostasis (GO:1900048) | 3.99479886 |
| 76 | amino-acid betaine metabolic process (GO:0006577) | 3.95956178 |
| 77 | regulation of cholesterol esterification (GO:0010872) | 3.95199158 |
| 78 | cholesterol efflux (GO:0033344) | 3.93017549 |
| 79 | arginine metabolic process (GO:0006525) | 3.89490809 |
| 80 | aromatic amino acid family metabolic process (GO:0009072) | 3.87559529 |
| 81 | high-density lipoprotein particle remodeling (GO:0034375) | 3.86779884 |
| 82 | tryptophan catabolic process (GO:0006569) | 3.82188825 |
| 83 | indole-containing compound catabolic process (GO:0042436) | 3.82188825 |
| 84 | indolalkylamine catabolic process (GO:0046218) | 3.82188825 |
| 85 | acute inflammatory response (GO:0002526) | 3.82142901 |
| 86 | negative regulation of lipase activity (GO:0060192) | 3.75766719 |
| 87 | positive regulation of lipid catabolic process (GO:0050996) | 3.72234860 |
| 88 | regulation of acute inflammatory response (GO:0002673) | 3.69622348 |
| 89 | positive regulation of coagulation (GO:0050820) | 3.66670213 |
| 90 | cellular ketone body metabolic process (GO:0046950) | 3.61372688 |
| 91 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.59233241 |
| 92 | serine family amino acid biosynthetic process (GO:0009070) | 3.58365861 |
| 93 | regulation of apoptotic cell clearance (GO:2000425) | 3.57144873 |
| 94 | cysteine metabolic process (GO:0006534) | 3.56244816 |
| 95 | reverse cholesterol transport (GO:0043691) | 3.55649232 |
| 96 | response to mercury ion (GO:0046689) | 3.53862009 |
| 97 | heme transport (GO:0015886) | 3.48808501 |
| 98 | steroid catabolic process (GO:0006706) | 3.48384476 |
| 99 | xenobiotic metabolic process (GO:0006805) | 3.45908022 |
| 100 | cellular amino acid catabolic process (GO:0009063) | 3.43138382 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.27321485 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.05799105 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.87066041 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.67223440 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.44206319 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.00177978 |
| 7 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.65886315 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.05201209 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.91420039 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.95119692 |
| 11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.04624956 |
| 12 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.00832008 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.4502319 |
| 14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.95642920 |
| 15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.90740110 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.86805003 |
| 17 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.66552159 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.50832332 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31251298 |
| 20 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.27441563 |
| 21 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.24181270 |
| 22 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.20401235 |
| 23 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.17019382 |
| 24 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.13989605 |
| 25 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.09058980 |
| 26 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.07849249 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 1.01574193 |
| 28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.99817522 |
| 29 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.97890369 |
| 30 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.97543150 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.97329361 |
| 32 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.92208293 |
| 33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.91498457 |
| 34 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.91021093 |
| 35 | * PHF8_20622853_ChIP-Seq_HELA_Human | 0.88995024 |
| 36 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.88515465 |
| 37 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.86405202 |
| 38 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.85313189 |
| 39 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.85005998 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.84565895 |
| 41 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.82694845 |
| 42 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.81700875 |
| 43 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.81535517 |
| 44 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.80972524 |
| 45 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.78095692 |
| 46 | AR_20517297_ChIP-Seq_VCAP_Human | 0.77357211 |
| 47 | * NFYA_21822215_ChIP-Seq_K562_Human | 0.77033330 |
| 48 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.76917472 |
| 49 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.75191789 |
| 50 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.74604533 |
| 51 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.73704053 |
| 52 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.73488289 |
| 53 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.71524513 |
| 54 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69470013 |
| 55 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.68826071 |
| 56 | CBP_21632823_ChIP-Seq_H3396_Human | 0.68492755 |
| 57 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.68474587 |
| 58 | * CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.67857306 |
| 59 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.66591825 |
| 60 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.65942113 |
| 61 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.65640905 |
| 62 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.63839232 |
| 63 | * ETV1_20927104_ChIP-Seq_GIST48_Human | 0.63524240 |
| 64 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.61897314 |
| 65 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.61736330 |
| 66 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.61696536 |
| 67 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.61683879 |
| 68 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.61162533 |
| 69 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.60982562 |
| 70 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.60935772 |
| 71 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.59500580 |
| 72 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.58534767 |
| 73 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.58238975 |
| 74 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.57524565 |
| 75 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.56602156 |
| 76 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.56468621 |
| 77 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.55782872 |
| 78 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.55722844 |
| 79 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.54994342 |
| 80 | * NFYB_21822215_ChIP-Seq_K562_Human | 0.54478821 |
| 81 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.54461096 |
| 82 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.54125798 |
| 83 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.53750232 |
| 84 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.53582792 |
| 85 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.52968103 |
| 86 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.52576376 |
| 87 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.52406905 |
| 88 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.52165083 |
| 89 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.52031920 |
| 90 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.51594928 |
| 91 | * PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.51404124 |
| 92 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.51054981 |
| 93 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.49598989 |
| 94 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.49529617 |
| 95 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.48424613 |
| 96 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.48257220 |
| 97 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.47934094 |
| 98 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.47328389 |
| 99 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.46543858 |
| 100 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.46289817 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 9.51474321 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 6.53112152 |
| 3 | MP0005360_urolithiasis | 6.19841120 |
| 4 | MP0005365_abnormal_bile_salt | 5.82135608 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.68081052 |
| 6 | MP0002138_abnormal_hepatobiliary_system | 5.03284390 |
| 7 | MP0003195_calcinosis | 5.00579576 |
| 8 | MP0003252_abnormal_bile_duct | 4.39783872 |
| 9 | MP0003868_abnormal_feces_composition | 3.45087346 |
| 10 | MP0001666_abnormal_nutrient_absorption | 3.13162679 |
| 11 | MP0009697_abnormal_copulation | 2.82434589 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.74796685 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.55755929 |
| 14 | MP0005332_abnormal_amino_acid | 2.39717765 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.11866861 |
| 16 | MP0000609_abnormal_liver_physiology | 1.89231126 |
| 17 | MP0010368_abnormal_lymphatic_system | 1.87912864 |
| 18 | MP0002876_abnormal_thyroid_physiology | 1.87094318 |
| 19 | MP0009840_abnormal_foam_cell | 1.84841672 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 1.68883413 |
| 21 | MP0001764_abnormal_homeostasis | 1.65700455 |
| 22 | MP0005670_abnormal_white_adipose | 1.32807580 |
| 23 | MP0004019_abnormal_vitamin_homeostasis | 1.31977004 |
| 24 | MP0001661_extended_life_span | 1.23693638 |
| 25 | MP0005408_hypopigmentation | 1.21396658 |
| 26 | MP0009053_abnormal_anal_canal | 1.19295875 |
| 27 | MP0005319_abnormal_enzyme/_coenzyme | 1.16123312 |
| 28 | MP0002132_abnormal_respiratory_system | 1.14296358 |
| 29 | MP0000598_abnormal_liver_morphology | 1.11029917 |
| 30 | MP0009764_decreased_sensitivity_to | 1.02767038 |
| 31 | MP0000604_amyloidosis | 0.99067817 |
| 32 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.95805121 |
| 33 | MP0003656_abnormal_erythrocyte_physiolo | 0.92968812 |
| 34 | MP0005187_abnormal_penis_morphology | 0.92846400 |
| 35 | MP0009643_abnormal_urine_homeostasis | 0.92698986 |
| 36 | MP0009763_increased_sensitivity_to | 0.89049189 |
| 37 | MP0001915_intracranial_hemorrhage | 0.87026300 |
| 38 | MP0002971_abnormal_brown_adipose | 0.85387852 |
| 39 | MP0003186_abnormal_redox_activity | 0.84243252 |
| 40 | MP0009642_abnormal_blood_homeostasis | 0.83864158 |
| 41 | MP0008469_abnormal_protein_level | 0.83633153 |
| 42 | MP0005376_homeostasis/metabolism_phenot | 0.83212506 |
| 43 | MP0005451_abnormal_body_composition | 0.80466285 |
| 44 | MP0002282_abnormal_trachea_morphology | 0.77997068 |
| 45 | MP0005395_other_phenotype | 0.73562045 |
| 46 | MP0003690_abnormal_glial_cell | 0.72034379 |
| 47 | MP0008872_abnormal_physiological_respon | 0.70242535 |
| 48 | MP0005636_abnormal_mineral_homeostasis | 0.67730197 |
| 49 | MP0005464_abnormal_platelet_physiology | 0.66288830 |
| 50 | MP0002168_other_aberrant_phenotype | 0.66050238 |
| 51 | MP0003879_abnormal_hair_cell | 0.64461343 |
| 52 | MP0008874_decreased_physiological_sensi | 0.63041133 |
| 53 | MP0005535_abnormal_body_temperature | 0.62461046 |
| 54 | MP0005266_abnormal_metabolism | 0.61647179 |
| 55 | MP0002249_abnormal_larynx_morphology | 0.61081911 |
| 56 | MP0009785_altered_susceptibility_to | 0.59904490 |
| 57 | MP0002078_abnormal_glucose_homeostasis | 0.58005272 |
| 58 | MP0003638_abnormal_response/metabolism_ | 0.56237120 |
| 59 | MP0005334_abnormal_fat_pad | 0.55352368 |
| 60 | MP0003011_delayed_dark_adaptation | 0.54539840 |
| 61 | MP0005023_abnormal_wound_healing | 0.51736999 |
| 62 | MP0009765_abnormal_xenobiotic_induced | 0.47202550 |
| 63 | MP0004130_abnormal_muscle_cell | 0.45830032 |
| 64 | MP0005166_decreased_susceptibility_to | 0.43770204 |
| 65 | MP0000249_abnormal_blood_vessel | 0.42251961 |
| 66 | MP0004782_abnormal_surfactant_physiolog | 0.40217204 |
| 67 | MP0005164_abnormal_response_to | 0.37248093 |
| 68 | MP0002136_abnormal_kidney_physiology | 0.35677129 |
| 69 | MP0002332_abnormal_exercise_endurance | 0.35531924 |
| 70 | MP0003075_altered_response_to | 0.34480476 |
| 71 | MP0009115_abnormal_fat_cell | 0.32486754 |
| 72 | MP0004883_abnormal_blood_vessel | 0.32162643 |
| 73 | MP0000467_abnormal_esophagus_morphology | 0.31715784 |
| 74 | MP0005448_abnormal_energy_balance | 0.30922009 |
| 75 | MP0006036_abnormal_mitochondrial_physio | 0.30321794 |
| 76 | MP0005058_abnormal_lysosome_morphology | 0.28967028 |
| 77 | MP0005220_abnormal_exocrine_pancreas | 0.28438871 |
| 78 | MP0001545_abnormal_hematopoietic_system | 0.28371503 |
| 79 | MP0005397_hematopoietic_system_phenotyp | 0.28371503 |
| 80 | MP0003705_abnormal_hypodermis_morpholog | 0.27966336 |
| 81 | MP0002928_abnormal_bile_duct | 0.27875961 |
| 82 | MP0001845_abnormal_inflammatory_respons | 0.27083224 |
| 83 | MP0003953_abnormal_hormone_level | 0.26092119 |
| 84 | MP0001851_eye_inflammation | 0.25596746 |
| 85 | MP0005083_abnormal_biliary_tract | 0.24962339 |
| 86 | MP0005647_abnormal_sex_gland | 0.21930124 |
| 87 | MP0002128_abnormal_blood_circulation | 0.21404850 |
| 88 | MP0000639_abnormal_adrenal_gland | 0.21290770 |
| 89 | MP0003959_abnormal_lean_body | 0.21093109 |
| 90 | MP0000566_synostosis | 0.20328079 |
| 91 | MP0008873_increased_physiological_sensi | 0.20178527 |
| 92 | MP0000920_abnormal_myelination | 0.19596016 |
| 93 | MP0003633_abnormal_nervous_system | 0.18778327 |
| 94 | MP0005197_abnormal_uvea_morphology | 0.18577088 |
| 95 | MP0002970_abnormal_white_adipose | 0.17857928 |
| 96 | MP0005084_abnormal_gallbladder_morpholo | 0.17013520 |
| 97 | MP0004272_abnormal_basement_membrane | 0.16970976 |
| 98 | MP0003436_decreased_susceptibility_to | 0.15558357 |
| 99 | MP0001881_abnormal_mammary_gland | 0.14819955 |
| 100 | MP0005666_abnormal_adipose_tissue | 0.14749999 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 9.74781283 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 8.79497428 |
| 3 | Abnormality of complement system (HP:0005339) | 8.77021057 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 8.54369743 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 7.66344049 |
| 6 | Conjugated hyperbilirubinemia (HP:0002908) | 7.18736962 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 6.54058424 |
| 8 | Joint hemorrhage (HP:0005261) | 6.21132050 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.84159930 |
| 10 | Intrahepatic cholestasis (HP:0001406) | 5.71972738 |
| 11 | Abnormality of the common coagulation pathway (HP:0010990) | 5.37856315 |
| 12 | Abnormality of pyrimidine metabolism (HP:0004353) | 5.30266779 |
| 13 | Spontaneous abortion (HP:0005268) | 5.17624389 |
| 14 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.99722235 |
| 15 | Xanthomatosis (HP:0000991) | 4.88884007 |
| 16 | * Glomerulonephritis (HP:0000099) | 4.62385003 |
| 17 | Hypolipoproteinemia (HP:0010981) | 4.42936592 |
| 18 | Abnormality of the intrinsic pathway (HP:0010989) | 4.02739668 |
| 19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.85356792 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 3.65838780 |
| 21 | Abnormality of methionine metabolism (HP:0010901) | 3.48213087 |
| 22 | * Nephritis (HP:0000123) | 3.44783839 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.43898173 |
| 24 | Gingival bleeding (HP:0000225) | 3.40975497 |
| 25 | Fat malabsorption (HP:0002630) | 3.26401608 |
| 26 | Hyperammonemia (HP:0001987) | 3.09517990 |
| 27 | Hyperglycinemia (HP:0002154) | 2.92801932 |
| 28 | Abnormality of nucleobase metabolism (HP:0010932) | 2.84802913 |
| 29 | Generalized aminoaciduria (HP:0002909) | 2.82275703 |
| 30 | Thrombophlebitis (HP:0004418) | 2.80841902 |
| 31 | Delayed CNS myelination (HP:0002188) | 2.77032264 |
| 32 | Hepatocellular carcinoma (HP:0001402) | 2.75515214 |
| 33 | Hypercholesterolemia (HP:0003124) | 2.73926001 |
| 34 | Hyperbilirubinemia (HP:0002904) | 2.71385546 |
| 35 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.68800339 |
| 36 | Neonatal hypoglycemia (HP:0001998) | 2.61641710 |
| 37 | Osteomalacia (HP:0002749) | 2.61350189 |
| 38 | Mitral stenosis (HP:0001718) | 2.59063353 |
| 39 | Purpura (HP:0000979) | 2.55789677 |
| 40 | Epidermoid cyst (HP:0200040) | 2.53835577 |
| 41 | Fair hair (HP:0002286) | 2.53653722 |
| 42 | Hemorrhage of the eye (HP:0011885) | 2.51424803 |
| 43 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.48876504 |
| 44 | Abnormality of glycine metabolism (HP:0010895) | 2.48876504 |
| 45 | Vascular calcification (HP:0004934) | 2.48708038 |
| 46 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.47039267 |
| 47 | Pulmonary embolism (HP:0002204) | 2.43399672 |
| 48 | Reduced antithrombin III activity (HP:0001976) | 2.42109164 |
| 49 | Abnormality of serum amino acid levels (HP:0003112) | 2.41485633 |
| 50 | Menorrhagia (HP:0000132) | 2.39821969 |
| 51 | Cholelithiasis (HP:0001081) | 2.36752081 |
| 52 | Steatorrhea (HP:0002570) | 2.30931397 |
| 53 | Rickets (HP:0002748) | 2.30796429 |
| 54 | Cholecystitis (HP:0001082) | 2.30649724 |
| 55 | Abnormal gallbladder physiology (HP:0012438) | 2.30649724 |
| 56 | Abnormal gallbladder morphology (HP:0012437) | 2.20549951 |
| 57 | Cardiovascular calcification (HP:0011915) | 2.20479526 |
| 58 | Elevated alkaline phosphatase (HP:0003155) | 2.15448728 |
| 59 | Joint swelling (HP:0001386) | 2.14276008 |
| 60 | Hyperglycinuria (HP:0003108) | 2.00959764 |
| 61 | Metabolic acidosis (HP:0001942) | 2.00867036 |
| 62 | Complement deficiency (HP:0004431) | 10.9347616 |
| 63 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 10.2901161 |
| 64 | Increased serum ferritin (HP:0003281) | 1.98994625 |
| 65 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.97690011 |
| 66 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.95213065 |
| 67 | Abnormality of iron homeostasis (HP:0011031) | 1.94691582 |
| 68 | Arthropathy (HP:0003040) | 1.93909515 |
| 69 | Abnormality of the Achilles tendon (HP:0005109) | 1.91183976 |
| 70 | Epistaxis (HP:0000421) | 1.88216725 |
| 71 | Gangrene (HP:0100758) | 1.83577598 |
| 72 | Ketosis (HP:0001946) | 1.82941037 |
| 73 | Irritability (HP:0000737) | 1.81161736 |
| 74 | Hyperphosphaturia (HP:0003109) | 1.80870479 |
| 75 | Myocardial infarction (HP:0001658) | 1.79336810 |
| 76 | Generalized hypopigmentation of hair (HP:0011358) | 1.78180546 |
| 77 | Cerebral palsy (HP:0100021) | 1.77989190 |
| 78 | Abnormal biliary tract physiology (HP:0012439) | 1.75568377 |
| 79 | Bile duct proliferation (HP:0001408) | 1.75568377 |
| 80 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.75505524 |
| 81 | Abnormality of vitamin metabolism (HP:0100508) | 1.75370118 |
| 82 | Gout (HP:0001997) | 1.73842571 |
| 83 | Abnormal delivery (HP:0001787) | 1.73805253 |
| 84 | Abnormality of purine metabolism (HP:0004352) | 1.72298642 |
| 85 | Pancreatitis (HP:0001733) | 1.65672001 |
| 86 | Atrioventricular block (HP:0001678) | 1.65421985 |
| 87 | Enlarged kidneys (HP:0000105) | 1.63802652 |
| 88 | Abnormality of urine glucose concentration (HP:0011016) | 1.63777978 |
| 89 | Glycosuria (HP:0003076) | 1.63777978 |
| 90 | Amyloidosis (HP:0011034) | 1.59582529 |
| 91 | Abnormality of the gallbladder (HP:0005264) | 1.59092375 |
| 92 | Increased mean platelet volume (HP:0011877) | 1.58653386 |
| 93 | Blue irides (HP:0000635) | 1.55948409 |
| 94 | Skin nodule (HP:0200036) | 1.53300024 |
| 95 | Hydroxyprolinuria (HP:0003080) | 1.50330886 |
| 96 | Abnormality of proline metabolism (HP:0010907) | 1.50330886 |
| 97 | Poikilocytosis (HP:0004447) | 1.47077061 |
| 98 | Lethargy (HP:0001254) | 1.46862915 |
| 99 | Abnormal urine phosphate concentration (HP:0012599) | 1.46283153 |
| 100 | Alkalosis (HP:0001948) | 1.46192660 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.46095169 |
| 2 | PIK3CG | 5.24108039 |
| 3 | FGFR4 | 3.90384987 |
| 4 | SIK1 | 2.92923871 |
| 5 | RIPK1 | 2.91756401 |
| 6 | TRIB3 | 2.81382818 |
| 7 | BCKDK | 2.53762504 |
| 8 | PRKACG | 2.39474800 |
| 9 | TYK2 | 2.37060174 |
| 10 | EPHA3 | 2.36520162 |
| 11 | PIK3CA | 2.21407105 |
| 12 | TAOK3 | 2.16739491 |
| 13 | MAP2K4 | 1.84697951 |
| 14 | PRKAA2 | 1.80635779 |
| 15 | MST1R | 1.65841371 |
| 16 | TBK1 | 1.60464582 |
| 17 | MAPK11 | 1.57984428 |
| 18 | PRPF4B | 1.56246271 |
| 19 | PRKCG | 1.55244074 |
| 20 | FGFR3 | 1.48704230 |
| 21 | JAK1 | 1.44981846 |
| 22 | NTRK3 | 1.40942348 |
| 23 | TNK2 | 1.30833423 |
| 24 | NLK | 1.29869410 |
| 25 | IGF1R | 1.24760474 |
| 26 | PDPK1 | 1.24259189 |
| 27 | MAP3K3 | 1.23787176 |
| 28 | ICK | 1.19973791 |
| 29 | FER | 1.18871641 |
| 30 | PRKG1 | 1.17467660 |
| 31 | NEK9 | 1.15789224 |
| 32 | ABL2 | 1.15785146 |
| 33 | FRK | 1.13953909 |
| 34 | EPHB1 | 1.09692311 |
| 35 | PDK2 | 1.09284934 |
| 36 | ERBB2 | 1.08073279 |
| 37 | MET | 1.07459443 |
| 38 | PKN2 | 0.97136788 |
| 39 | CAMKK2 | 0.95003982 |
| 40 | PRKCZ | 0.93263362 |
| 41 | TIE1 | 0.92761870 |
| 42 | PRKACA | 0.91728077 |
| 43 | PDK1 | 0.91002781 |
| 44 | INSRR | 0.90316577 |
| 45 | ZAP70 | 0.89794002 |
| 46 | MAP3K1 | 0.88956811 |
| 47 | JAK2 | 0.87724045 |
| 48 | CSF1R | 0.85583721 |
| 49 | EPHA4 | 0.84689320 |
| 50 | PRKAA1 | 0.83528155 |
| 51 | STK38 | 0.83464695 |
| 52 | BLK | 0.82970578 |
| 53 | KDR | 0.80309732 |
| 54 | MAPK12 | 0.78808555 |
| 55 | MAP3K2 | 0.78550031 |
| 56 | MAPK7 | 0.77665762 |
| 57 | MYLK | 0.73858318 |
| 58 | SCYL2 | 0.71816388 |
| 59 | CAMKK1 | 0.70828229 |
| 60 | CSNK1D | 0.70473733 |
| 61 | ERBB4 | 0.70121061 |
| 62 | AKT3 | 0.69091097 |
| 63 | PRKCB | 0.66663111 |
| 64 | CDK6 | 0.65873261 |
| 65 | PRKACB | 0.64934545 |
| 66 | RET | 0.64820277 |
| 67 | SGK1 | 0.64260911 |
| 68 | FLT3 | 0.63077684 |
| 69 | RPS6KA3 | 0.62149026 |
| 70 | WNK3 | 0.61462980 |
| 71 | PRKCA | 0.61300874 |
| 72 | CSNK1E | 0.60947742 |
| 73 | PINK1 | 0.58651985 |
| 74 | TGFBR2 | 0.58623508 |
| 75 | MAPK4 | 0.58486805 |
| 76 | MAP3K6 | 0.55554066 |
| 77 | ARAF | 0.52092291 |
| 78 | GSK3A | 0.49703646 |
| 79 | MAP2K3 | 0.49543066 |
| 80 | SRC | 0.49384000 |
| 81 | TAOK2 | 0.48674342 |
| 82 | SGK223 | 0.47072319 |
| 83 | SGK494 | 0.47072319 |
| 84 | CSNK2A1 | 0.46316195 |
| 85 | MAP3K11 | 0.45125603 |
| 86 | MUSK | 0.45050623 |
| 87 | CDK4 | 0.43858296 |
| 88 | DYRK1B | 0.42282145 |
| 89 | SGK2 | 0.39495862 |
| 90 | CAMK2G | 0.38278635 |
| 91 | BRSK2 | 0.37979617 |
| 92 | CSNK2A2 | 0.37283230 |
| 93 | NTRK1 | 0.37119665 |
| 94 | IKBKE | 0.34582999 |
| 95 | MAPK3 | 0.34527752 |
| 96 | SGK3 | 0.34482597 |
| 97 | DAPK2 | 0.34192791 |
| 98 | MTOR | 0.33528971 |
| 99 | KIT | 0.33242122 |
| 100 | MAPK10 | 0.32610286 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.71473494 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.29160044 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.77580042 |
| 4 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.72324601 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.51577285 |
| 6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.45719164 |
| 7 | Retinol metabolism_Homo sapiens_hsa00830 | 3.39489203 |
| 8 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.85113006 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.83801380 |
| 10 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.83334139 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.74914981 |
| 12 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.66279491 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.63560934 |
| 14 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.56672405 |
| 15 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.48379773 |
| 16 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.34772039 |
| 17 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.31449919 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.09639766 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92337707 |
| 20 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.86088686 |
| 21 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.81220612 |
| 22 | Bile secretion_Homo sapiens_hsa04976 | 1.78177415 |
| 23 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.72193671 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.65044306 |
| 25 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.59901344 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.57806077 |
| 27 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.55473986 |
| 28 | Prion diseases_Homo sapiens_hsa05020 | 1.48086488 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.46713575 |
| 30 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.41259215 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.35373533 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.34776406 |
| 33 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.33232311 |
| 34 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.25286002 |
| 35 | Peroxisome_Homo sapiens_hsa04146 | 1.21907712 |
| 36 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.18022509 |
| 37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.14412215 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.14152354 |
| 39 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.13904853 |
| 40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.09103575 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.01377021 |
| 42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.96007267 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.87082489 |
| 44 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.85853700 |
| 45 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.85726010 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 0.85227001 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82257682 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 0.81776484 |
| 49 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79334403 |
| 50 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.69694849 |
| 51 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.69284467 |
| 52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.67703407 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.60310021 |
| 54 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.59035219 |
| 55 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.58688059 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.55973432 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.48418054 |
| 58 | Pertussis_Homo sapiens_hsa05133 | 0.42633552 |
| 59 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41226891 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 0.36248970 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.29729206 |
| 62 | Insulin resistance_Homo sapiens_hsa04931 | 0.26919413 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.25419808 |
| 64 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.24667560 |
| 65 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22680314 |
| 66 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.18790096 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.17320953 |
| 68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.14936606 |
| 69 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.07789803 |
| 70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.07027652 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.06810635 |
| 72 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.05847989 |
| 73 | Amoebiasis_Homo sapiens_hsa05146 | 0.05449023 |
| 74 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.05409378 |
| 75 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.04351555 |
| 76 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03525196 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.02736731 |
| 78 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.02573245 |
| 79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.01610318 |
| 80 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.2892099 |
| 81 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.2589842 |
| 82 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.2434436 |
| 83 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2307272 |
| 84 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2294925 |
| 85 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2267792 |
| 86 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2033194 |
| 87 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1994283 |
| 88 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1930847 |
| 89 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1821081 |
| 90 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.1703347 |
| 91 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1447172 |
| 92 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.1415923 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1170509 |
| 94 | Mineral absorption_Homo sapiens_hsa04978 | -0.0972190 |
| 95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0672509 |
| 96 | Steroid biosynthesis_Homo sapiens_hsa00100 | -0.0655319 |
| 97 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0148687 |
| 98 | Glutathione metabolism_Homo sapiens_hsa00480 | -0.0092479 |
| 99 | Selenocompound metabolism_Homo sapiens_hsa00450 | -0.0064689 |
| 100 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0060669 |

